Ozanimod should be prescribed to treat relapsing multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
PHARMACOLOGY UPDATE
Ozanimod Capsules (Zeposia)
May 15, 2020